{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:49:43Z","timestamp":1787240983848,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bioorg.2020.104618","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T16:24:13Z","timestamp":1610036653000},"page":"104618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX\/XII inhibitors"],"prefix":"10.1016","volume":"107","author":[{"given":"Mostafa M.","family":"Ghorab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiten M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104618_b0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2174\/1568011024606389","article-title":"Recent progress in the development of anticancer agents","volume":"2","author":"Eckhardt","year":"2002","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.bioorg.2020.104618_b0010","first-page":"5533","article-title":"Beyond DNA cross-linking: history and prospects of DNA-targeted cancer treatment\u2014fifteenth Bruce F Cain Memorial Award Lecture","volume":"56","author":"Kohn","year":"1996","journal-title":", Cancer Res."},{"key":"10.1016\/j.bioorg.2020.104618_b0015","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrd2137","article-title":"Tumour-initiating cells: challenges and opportunities for anticancer drug discovery","volume":"8","author":"Zhou","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104618_b0020","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2020.104618_b0025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104618_b0035","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.96.26.15184","article-title":"Carbonic anhydrase is an ancient enzyme widespread in prokaryotes","volume":"96","author":"Smith","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104618_b0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104618_b0045","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/ijms20153841","article-title":"Role of Carbonic Anhydrases and Inhibitors in Acid-Base Physiology: Insights from Mathematical Modeling","volume":"20","author":"Occhipinti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.104618_b0050","first-page":"1","article-title":"Carbonic anhydrase: its inhibitors and activators","author":"Supuran","year":"2004","journal-title":"CRC Press"},{"key":"10.1016\/j.bioorg.2020.104618_b0055","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1517\/13543776.13.10.1545","article-title":"Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity","volume":"13","author":"Supuran","year":"2003","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2020.104618_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186180","article-title":"Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: a meta-analysis","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2020.104618_b0065","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2020.104618_b0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-6147(02)01899-0","article-title":"Carbonic anhydrase gating of attention: memory therapy and enhancement","volume":"23","author":"Sun","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2020.104618_b0075","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2020.104618_b0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2423(06)42005-9","article-title":"Tumor-associated carbonic anhydrases and their clinical significance","volume":"42","author":"Pastorekova","year":"2006","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0085","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: an update","volume":"7","author":"Supuran","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejmech.2014.09.059","article-title":"Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: synthesis, cytotoxic activity and molecular modeling","volume":"87","author":"Ghorab","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112333","article-title":"Antioxidant activity of novel quinazolinones bearing sulfonamide: Potential radiomodulatory effects on liver tissues via NF-\u03baB\/PON1 pathway","volume":"197","author":"Soliman","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112467","article-title":"Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinolin-4 (3H)-ones carrying a sulfonamide moiety","volume":"200","author":"Soliman","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0110","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.2147\/IJN.S241433","article-title":"Novel N-(substituted) thioacetamide quinazolinone benzenesulfonamides as antimicrobial agents","volume":"15","author":"Ghorab","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2020.104618_b0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1747-0285.2009.00794.x","article-title":"3-(3-Ethylphenyl)-2-substituted hydrazino-3h-quinazolin-4-one derivatives: new class of analgesic and anti-inflammatory agents","volume":"73","author":"Alagarsamy","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2020.104618_b0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jps.2600630428","article-title":"Anti-inflammatory activity of para-substituted N-benzenesulfonyl derivatives of anthranilic acid","volume":"63","author":"Borne","year":"1974","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2020.104618_b0125","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bioorg.2018.07.015","article-title":"Dual EGFR\/HER2 inhibitors and apoptosis inducers: New benzo [g] quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers","volume":"80","author":"Ghorab","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0130","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/14756366.2019.1609469","article-title":"Novel sulfonamide benzoquinazolinones as dual EGFR\/HER2 inhibitors, apoptosis inducers and radiosensitizers","volume":"34","author":"Soliman","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0135","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1016\/j.bmcl.2009.05.113","article-title":"Identification of substituted pyrazolo [1, 5-a] quinazolin-5 (4H)-one as potent poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors","volume":"19","author":"Orvieto","year":"2009","journal-title":"Bioorg. Med. Chem. lett."},{"key":"10.1016\/j.bioorg.2020.104618_b0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2012.12.061","article-title":"Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones","volume":"63","author":"Al-Omary","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0145","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1016\/j.bmcl.2006.08.058","article-title":"4\u2032-Alkoxyl substitution enhancing the anti-mitotic effect of 5-(3\u2032, 4\u2032, 5\u2032-substituted) anilino-4-hydroxy-8-nitroquinazolines as a novel class of anti-microtubule agents","volume":"16","author":"Jin","year":"2006","journal-title":"Bioorg. Med. Chem. lett."},{"key":"10.1016\/j.bioorg.2020.104618_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102956","article-title":"Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3, 4-dihydroquinazolin-2-yl) thio] acetamide derivatives as anticancer and radiosensitizing agents","volume":"88","author":"Soliman","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14756366.2017.1389922","article-title":"Benzo [g] quinazolin-based scaffold derivatives as dual EGFR\/HER2 inhibitors","volume":"33","author":"Ghorab","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejmech.2017.09.061","article-title":"Discovery of Benzo [g] quinazolin benzenesulfonamide derivatives as dual EGFR\/HER2 inhibitors","volume":"141","author":"Alsaid","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0165","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/14756366.2017.1334650","article-title":"VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo [g] quinazolin bearing benzenesulfonamide moiety","volume":"32","author":"Ghorab","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-0711-7-17","article-title":"Antimicrobial activity of some sulfonamide derivatives on clinical isolates of Staphylococus aureus","volume":"7","author":"Gen\u00e7","year":"2008","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.bioorg.2020.104618_b0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.arabjc.2017.05.022","article-title":"Synthesis, antimicrobial activity and docking study of some novel 4-(4, 4-dimethyl-2, 6-dioxocyclohexylidene) methylamino derivatives carrying biologically active sulfonamide moiety","volume":"13","author":"Ghorab","year":"2020","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0180","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s12272-013-0094-6","article-title":"Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus","volume":"36","author":"Ghorab","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioorg.2020.104618_b0185","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2174\/1871520617666170327153735","article-title":"Novel thiourea derivatives bearing sulfonamide moiety as anticancer agents through COX-2 inhibition","volume":"17","author":"Ghorab","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0190","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ejmech.2016.10.020","article-title":"Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers","volume":"124","author":"Ghorab","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0195","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bioorg.2019.03.007","article-title":"Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitors","volume":"87","author":"El-Azab","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112449","article-title":"Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity","volume":"200","author":"Soliman","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0210","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0142-9612(93)90055-7","article-title":"In vitro evaluation of cell\/biomaterial interaction by MTT assay","volume":"14","author":"Ciapetti","year":"1993","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioorg.2020.104618_b0215","unstructured":"M. Suffness, Assays related to cancer drug discovery, Methods in plant biochemistry: assays for bioactivity 6 (1990) 71\u2013133."},{"key":"10.1016\/j.bioorg.2020.104618_b0220","doi-asserted-by":"crossref","first-page":"1-A-3B","DOI":"10.1002\/0471142735.ima03bs21","article-title":"Trypan blue exclusion test of cell viability","volume":"21","author":"Strober","year":"1997","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.bioorg.2020.104618_b0225","first-page":"2487","article-title":"Novel radiosensitizing anticancer therapeutics","volume":"32","author":"Linkous","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2020.104618_b0230","doi-asserted-by":"crossref","unstructured":"T.B. Brunner, L.A. Kunz-Schughart, P. Grosse-Gehling, M. Baumann, Cancer stem cells as a predictive factor in radiotherapy, Seminars in radiation oncology, Elsevier, 2012, pp. 151\u2013174.","DOI":"10.1016\/j.semradonc.2011.12.003"},{"key":"10.1016\/j.bioorg.2020.104618_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111896","article-title":"Sulfonamide\/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors","volume":"186","author":"Nocentini","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0240","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/acsmedchemlett.8b00362","article-title":"Heterocoumarins are selective carbonic anhydrase IX and XII inhibitors with cytotoxic effects against cancer cells lines","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104618_b0245","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/acs.jmedchem.8b00625","article-title":"Discovery of \u03b2-adrenergic receptors blocker-carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy","volume":"61","author":"Nocentini","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104618_b0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bioorg.2018.01.023","article-title":"Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors","volume":"77","author":"Nocentini","year":"2018","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820319167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820319167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:17:00Z","timestamp":1758615420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820319167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":50,"alternative-id":["S0045206820319167"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104618","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX\/XII inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104618"}}